Additionally, PLK1 is closely linked to tumor immunotherapy, with its expression showing significant correlations with immunophenotyping, immune cell infiltration, tumor mutational burden (TMB), microsatellite instability (MSI), immune checkpoint gene activity, and therapeutic outcomes across various tumor types (8). This evidence concerns the gene PLK1 and neoplasm.